A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies

•The seropositive rates in patients with hematological malignancies after first and second vaccine dose were 30.0% and 62.3%, respectively.•These patients were less likely to develop antibody response as compared to cases with solid tumors and healthy subjects following complete immunization.•Chroni...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International immunopharmacology 2022-09, Vol.110, p.109046-109046, Article 109046
Hauptverfasser:	Noori, Maryam, Azizi, Shadi, Abbasi Varaki, Farhan, Nejadghaderi, Seyed Aria, Bashash, Davood
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Viral COVID-19 COVID-19 Vaccines Hematologic Neoplasms - therapy Hematological malignancy Humans Immunity Immunogenicity Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Myeloma SARS-CoV-2 Systematic review Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!